NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-051c39
Description
NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
Offer reference number: CM/PHG/24/5716
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/24/5716/01- NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide.
CESW: (Midlands and Southwest): 1st June 2026 - 31st May 2028
NWLN: (Northwest and London North): 1st June 2026 - 31st May 2028
LSNE: (London South and Northeast): 1st June 2026 - 31st May 2028
Notices
UK4: Tender notice
- Notice identifier
- 2026/S 000-010573
- Published
- 5 February 2026, 3:03pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2026/S 000-006070
- Published
- 23 January 2026, 10:29am
UK1: Pipeline notice
- Notice identifier
- 2025/S 000-024360
- Published
- 21 May 2025, 6:39pm